首页 > 最新文献

Annali dell'Istituto superiore di sanita最新文献

英文 中文
Live biotherapeutic products and their regulatory framework in Italy and Europe. 活性生物治疗产品及其在意大利和欧洲的监管框架。
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.4415/ANN_23_01_09
Giovanna Franciosa, Serena Guida, Maria Jesus Gomez Miguel, Christina Von Hunolstein

In Italy and Europe, live microorganisms-containing products meant to be used by vulnerable or sick people for preventing or curing a disease are defined as live biotherapeutic products and are regulated as biological drugs. As such, they must undergo extensive quality, safety and efficacy testing and evaluation before receiving a marketing authorization. This review describes the regulatory framework of live biotherapeutic products with special focus on the European Pharmacopoeia monograph 3053 that set mandatory requirements for this kind of medicines, including verification of the number of live microorganisms and absence of certain contamination indicator microorganisms. The other product categories that may contain live microorganisms are also described, with brief references to the overlaps possibly occurring between the different categories.

在意大利和欧洲,含有活微生物的产品被定义为活生物治疗产品,供易受伤害或患病的人用于预防或治疗疾病,并作为生物药物进行监管。因此,在获得上市许可之前,它们必须经过广泛的质量、安全性和有效性测试和评估。本综述描述了活体生物治疗产品的监管框架,特别关注欧洲药典专著3053,该专著为这类药物设定了强制性要求,包括验证活微生物的数量和缺乏某些污染指示微生物。还描述了可能含有活微生物的其他产品类别,并简要介绍了不同类别之间可能发生的重叠。
{"title":"Live biotherapeutic products and their regulatory framework in Italy and Europe.","authors":"Giovanna Franciosa,&nbsp;Serena Guida,&nbsp;Maria Jesus Gomez Miguel,&nbsp;Christina Von Hunolstein","doi":"10.4415/ANN_23_01_09","DOIUrl":"https://doi.org/10.4415/ANN_23_01_09","url":null,"abstract":"<p><p>In Italy and Europe, live microorganisms-containing products meant to be used by vulnerable or sick people for preventing or curing a disease are defined as live biotherapeutic products and are regulated as biological drugs. As such, they must undergo extensive quality, safety and efficacy testing and evaluation before receiving a marketing authorization. This review describes the regulatory framework of live biotherapeutic products with special focus on the European Pharmacopoeia monograph 3053 that set mandatory requirements for this kind of medicines, including verification of the number of live microorganisms and absence of certain contamination indicator microorganisms. The other product categories that may contain live microorganisms are also described, with brief references to the overlaps possibly occurring between the different categories.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9567939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two years of COVID-19. Impacts on accessibility of a mental health service for immigrants and individuals in socio-economic difficulties. 两年的COVID-19。对移民和社会经济困难个人获得精神卫生服务的影响。
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.4415/ANN_23_01_02
Massimiliano Aragona, Gianluca Nicolella, Giovanna Laurendi, Andrea Cavani, Gianfranco Costanzo, Concetta Mirisola

Objectives: Mental health services utilization decreased dramatically during the COVID-19 pandemic. For persons who are highly vulnerable and at risk of health and social care exclusion, restrictions negatively affected the accessibility to treatments and their mental conditions.

Methods: All psychiatric and psychological interviews carried out at National Institute for Health, Migration and Poverty (INMP) Italy from January 2018 to February 2022 were included in the study. To measure services use, an interrupted time-series analysis using March 2020 as the starting data of COVID-19 pandemic period was considered, and first visits vs follow-up session numbered.

Results: A significant decrease was observed in March 2020 due to the lockdown restrictive measures (p<0.001). Later on, the number of psychological interventions significantly increased (p<0.05), whereas the increment of the psychiatric interventions was not significant. By the end of February 2022 the number of visits returned to pre-COVID-19 levels, although recovery was slower than expected, especially for psychiatric visits.

Conclusions: After a dramatic drop during the lockdown, access to mental health out-patient clinics slowly returned to pre-pandemic levels in the next two years. Considering that mental health needs have increased during the pandemic, mental health services should improve their efforts to reduce barriers of access and to implement outreach referral.

目的:2019冠状病毒病大流行期间,精神卫生服务使用率大幅下降。对于极度脆弱和有可能被排除在保健和社会照顾之外的人来说,各种限制对获得治疗及其精神状况产生了不利影响。方法:2018年1月至2022年2月在意大利国家卫生、移民和贫困研究所(INMP)进行的所有精神病学和心理学访谈都被纳入研究。为了衡量服务的使用情况,我们考虑了以2020年3月为COVID-19大流行时期的起始数据进行中断时间序列分析,并对首次就诊人数与随访人数进行了编号。结果:由于封锁限制措施,2020年3月观察到显着下降(结论:在封锁期间急剧下降之后,精神卫生门诊诊所的使用率在接下来的两年里慢慢恢复到大流行前的水平。鉴于大流行期间心理健康需求有所增加,心理健康服务机构应加强努力,减少获得服务的障碍,并实施外联转诊。
{"title":"Two years of COVID-19. Impacts on accessibility of a mental health service for immigrants and individuals in socio-economic difficulties.","authors":"Massimiliano Aragona,&nbsp;Gianluca Nicolella,&nbsp;Giovanna Laurendi,&nbsp;Andrea Cavani,&nbsp;Gianfranco Costanzo,&nbsp;Concetta Mirisola","doi":"10.4415/ANN_23_01_02","DOIUrl":"https://doi.org/10.4415/ANN_23_01_02","url":null,"abstract":"<p><strong>Objectives: </strong>Mental health services utilization decreased dramatically during the COVID-19 pandemic. For persons who are highly vulnerable and at risk of health and social care exclusion, restrictions negatively affected the accessibility to treatments and their mental conditions.</p><p><strong>Methods: </strong>All psychiatric and psychological interviews carried out at National Institute for Health, Migration and Poverty (INMP) Italy from January 2018 to February 2022 were included in the study. To measure services use, an interrupted time-series analysis using March 2020 as the starting data of COVID-19 pandemic period was considered, and first visits vs follow-up session numbered.</p><p><strong>Results: </strong>A significant decrease was observed in March 2020 due to the lockdown restrictive measures (p<0.001). Later on, the number of psychological interventions significantly increased (p<0.05), whereas the increment of the psychiatric interventions was not significant. By the end of February 2022 the number of visits returned to pre-COVID-19 levels, although recovery was slower than expected, especially for psychiatric visits.</p><p><strong>Conclusions: </strong>After a dramatic drop during the lockdown, access to mental health out-patient clinics slowly returned to pre-pandemic levels in the next two years. Considering that mental health needs have increased during the pandemic, mental health services should improve their efforts to reduce barriers of access and to implement outreach referral.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9567937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnosis of Respiratory Syncytial Virus (RSV) infection in children by Respiratory Panel utilized during the COVID-19 pandemic. 利用COVID-19大流行期间使用的呼吸专家组诊断儿童呼吸道合胞病毒(RSV)感染
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.4415/ANN_23_01_05
Paola Alessandra Petrocelli, Veronica Cunsolo, Marianna Melito, Giovanni Scuderi, Rebecca Testa, Stefano Messina, Francesca Tucci, Lorenzo Sardone, Daria Colligiani, Maria Nardone, Stefano Rapi, Elisabetta Stenner

Background: In the months of October and November 2021, there was throughout Italy and in our specific case in the area of Lucca and Versilia, a disturbing increase of SARS-CoV-2 infections and cases of Respiratory Syncytial Virus (RSV) in new-borns. The aim of this paper is to compare the cases of RSV infection diagnosed in recent years to the cases recorded during the SARS-CoV-2 pandemic to November 2022.

Materials and methods: The study consisted of evaluating the results of requests for RSV diagnosis from 2015 to November 2022, using molecular biology techniques.

Results: The data obtained show that the number of cases of RSV infection in children during the winter season had a constant trend from 2015 to 2019. From November 2020 to February 2021 there were no cases of RSV respiratory infections. Starting from September 2021, on the other hand, there was a resumption of cases of RSV infections in conjunction with an increase in the number of children affected by COVID-19. From January 2022, after a peak in cases of SARS-CoV-2 infection, there has been a decrease in RSV infections. From September 2022 to November 2022, there was no increase of cases of RSV infections in new-borns but on the contrary, there was a trend in respiratory infections comparable to the pre-pandemic period.

Conclusion: The data that emerged from the study conducted, show the onset of an outbreak of RSV in new-borns. This incidence is linked to the implementation of rigorous non-pharmacological public health interventions in 2020, aimed at combating COVID-19 infection. The use of the molecular panel made it possible to identifying the responsible agent and highlighting the most suitable clinical and therapeutic path.

背景:在2021年10月和11月,在整个意大利,以及我们在卢卡和凡尔赛利亚地区的具体病例中,新生儿中SARS-CoV-2感染和呼吸道合胞病毒(RSV)病例的增加令人不安。本文的目的是将近年来诊断的RSV感染病例与截至2022年11月的SARS-CoV-2大流行期间记录的病例进行比较。材料与方法:本研究利用分子生物学技术评估2015年至2022年11月RSV诊断请求的结果。结果:获得的数据显示,2015 - 2019年冬季儿童RSV感染病例数呈恒定趋势。从2020年11月至2021年2月,无呼吸道合胞病毒感染病例。另一方面,从2021年9月开始,呼吸道合胞病毒感染病例再次出现,同时受COVID-19影响的儿童人数有所增加。从2022年1月起,在SARS-CoV-2感染病例达到高峰后,呼吸道合胞病毒感染有所减少。从2022年9月至2022年11月,新生儿呼吸道合胞病毒感染病例没有增加,但相反,呼吸道感染的趋势与大流行前时期相当。结论:从研究中得出的数据显示,呼吸道合胞病毒在新生儿中爆发。这一发病率与2020年实施严格的非药物公共卫生干预措施有关,旨在防治COVID-19感染。分子面板的使用使得确定负责的药物和突出最合适的临床和治疗途径成为可能。
{"title":"Diagnosis of Respiratory Syncytial Virus (RSV) infection in children by Respiratory Panel utilized during the COVID-19 pandemic.","authors":"Paola Alessandra Petrocelli,&nbsp;Veronica Cunsolo,&nbsp;Marianna Melito,&nbsp;Giovanni Scuderi,&nbsp;Rebecca Testa,&nbsp;Stefano Messina,&nbsp;Francesca Tucci,&nbsp;Lorenzo Sardone,&nbsp;Daria Colligiani,&nbsp;Maria Nardone,&nbsp;Stefano Rapi,&nbsp;Elisabetta Stenner","doi":"10.4415/ANN_23_01_05","DOIUrl":"https://doi.org/10.4415/ANN_23_01_05","url":null,"abstract":"<p><strong>Background: </strong>In the months of October and November 2021, there was throughout Italy and in our specific case in the area of Lucca and Versilia, a disturbing increase of SARS-CoV-2 infections and cases of Respiratory Syncytial Virus (RSV) in new-borns. The aim of this paper is to compare the cases of RSV infection diagnosed in recent years to the cases recorded during the SARS-CoV-2 pandemic to November 2022.</p><p><strong>Materials and methods: </strong>The study consisted of evaluating the results of requests for RSV diagnosis from 2015 to November 2022, using molecular biology techniques.</p><p><strong>Results: </strong>The data obtained show that the number of cases of RSV infection in children during the winter season had a constant trend from 2015 to 2019. From November 2020 to February 2021 there were no cases of RSV respiratory infections. Starting from September 2021, on the other hand, there was a resumption of cases of RSV infections in conjunction with an increase in the number of children affected by COVID-19. From January 2022, after a peak in cases of SARS-CoV-2 infection, there has been a decrease in RSV infections. From September 2022 to November 2022, there was no increase of cases of RSV infections in new-borns but on the contrary, there was a trend in respiratory infections comparable to the pre-pandemic period.</p><p><strong>Conclusion: </strong>The data that emerged from the study conducted, show the onset of an outbreak of RSV in new-borns. This incidence is linked to the implementation of rigorous non-pharmacological public health interventions in 2020, aimed at combating COVID-19 infection. The use of the molecular panel made it possible to identifying the responsible agent and highlighting the most suitable clinical and therapeutic path.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9567942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Neurorehabilitation of severe acquired brain injury in the time of COVID-19: impact of the absence of caregivers. COVID-19时期重症获得性脑损伤的神经康复:护理人员缺失的影响
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2022-10-01 DOI: 10.4415/ANN_22_04_03
Maria De Luca, Valentina Bandiera, Elena D'Aviero, Benedetta Onofri, Fabiana Mungiello, Giulia Ferri, Manuela Iannetti, Susanna Lucatello, Rita Formisano, Umberto Bivona

Introduction: During the COVID-19 pandemic, several restrictions were imposed to limit the circulation of the infection within communities. Hospitals denied access to the family and friends of inpatients, and thus to caregivers. This observational study evaluated the impact of the physical absence of caregivers during the lockdown period due to the COVID-19 emergency on the rehabilitation of inpatients with severe acquired brain injury (sABI).

Methods: The functional outcome at discharge was measured in 25 inpatients with sABI through the Disability Rating Scale (DRS), Glasgow Outcome Scale (GOS), and Levels of Cognitive Functioning scale (LCF) after neuropsychological rehabilitation in an Adult Inpatient Neurorehabilitation Unit for Patients with sABI. Fourteen patients were directly assisted by their informal caregivers physically present in the neurorehabilitation ward. Eleven patients were indirectly supported via remote connection because during the lockdown period (from March to July 2020) caregivers could not be admitted to the rehabilitation hospital. The Caregiving Impact on Neuro-Rehabilitation Scale (CINRS) was also used to evaluate both the change since the admission and the impact of the caregiver from the perspective of the cognitive therapist. Demographic characteristics, time since injury, injury severity (duration of impaired consciousness measured by the time to follow commands), level of functioning at the beginning of the rehabilitation, and duration of the rehabilitation treatment were comparable between the groups.

Results: Both groups improved after the treatment; however, the improvement was consistently greater in the group directly assisted by the caregivers. The results showed that although the caregivers ensured their virtual presence at distance, their physical absence played a role in hindering the functional outcome of the patients.

Conclusions: The role of the caregiver of patients with sABI is underlined in being not only a person handing out generic aid, cares, and affection, but also an integral part of the rehabilitation process.

导言:在2019冠状病毒病大流行期间,实施了若干限制措施,以限制感染在社区内的传播。医院不让住院病人的家人和朋友接触,因此也不让护理人员接触。本观察性研究评估了COVID-19紧急情况导致的封锁期间护理人员缺席对重症获得性脑损伤(sABI)住院患者康复的影响。方法:采用残疾评定量表(DRS)、格拉斯哥结果量表(GOS)和认知功能水平量表(LCF)对25例sABI住院患者进行神经心理康复后出院时的功能结局进行测量。14名患者由他们的非正式护理人员直接在神经康复病房提供帮助。11名患者通过远程连接得到间接支持,因为在封锁期间(2020年3月至7月)护理人员无法入住康复医院。采用认知治疗师视角的护理影响神经康复量表(CINRS)评估入院后的变化和护理者的影响。两组患者的人口学特征、受伤后的时间、受伤严重程度(通过服从命令的时间来测量意识受损的持续时间)、康复开始时的功能水平和康复治疗的持续时间具有可比性。结果:两组治疗后均有改善;然而,由护理人员直接帮助的小组的改善一直更大。结果表明,尽管护理人员确保了他们在远处的虚拟存在,但他们的实际缺席在阻碍患者的功能结果方面发挥了作用。结论:sABI患者的照顾者的角色不仅是一个提供一般帮助、照顾和情感的人,而且是康复过程中不可或缺的一部分。
{"title":"Neurorehabilitation of severe acquired brain injury in the time of COVID-19: impact of the absence of caregivers.","authors":"Maria De Luca,&nbsp;Valentina Bandiera,&nbsp;Elena D'Aviero,&nbsp;Benedetta Onofri,&nbsp;Fabiana Mungiello,&nbsp;Giulia Ferri,&nbsp;Manuela Iannetti,&nbsp;Susanna Lucatello,&nbsp;Rita Formisano,&nbsp;Umberto Bivona","doi":"10.4415/ANN_22_04_03","DOIUrl":"https://doi.org/10.4415/ANN_22_04_03","url":null,"abstract":"<p><strong>Introduction: </strong>During the COVID-19 pandemic, several restrictions were imposed to limit the circulation of the infection within communities. Hospitals denied access to the family and friends of inpatients, and thus to caregivers. This observational study evaluated the impact of the physical absence of caregivers during the lockdown period due to the COVID-19 emergency on the rehabilitation of inpatients with severe acquired brain injury (sABI).</p><p><strong>Methods: </strong>The functional outcome at discharge was measured in 25 inpatients with sABI through the Disability Rating Scale (DRS), Glasgow Outcome Scale (GOS), and Levels of Cognitive Functioning scale (LCF) after neuropsychological rehabilitation in an Adult Inpatient Neurorehabilitation Unit for Patients with sABI. Fourteen patients were directly assisted by their informal caregivers physically present in the neurorehabilitation ward. Eleven patients were indirectly supported via remote connection because during the lockdown period (from March to July 2020) caregivers could not be admitted to the rehabilitation hospital. The Caregiving Impact on Neuro-Rehabilitation Scale (CINRS) was also used to evaluate both the change since the admission and the impact of the caregiver from the perspective of the cognitive therapist. Demographic characteristics, time since injury, injury severity (duration of impaired consciousness measured by the time to follow commands), level of functioning at the beginning of the rehabilitation, and duration of the rehabilitation treatment were comparable between the groups.</p><p><strong>Results: </strong>Both groups improved after the treatment; however, the improvement was consistently greater in the group directly assisted by the caregivers. The results showed that although the caregivers ensured their virtual presence at distance, their physical absence played a role in hindering the functional outcome of the patients.</p><p><strong>Conclusions: </strong>The role of the caregiver of patients with sABI is underlined in being not only a person handing out generic aid, cares, and affection, but also an integral part of the rehabilitation process.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10342987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Characteristics of COVID-19 cases in Italy from a sex/gender perspective. 从性别/性别角度看意大利COVID-19病例的特征
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2022-10-01 DOI: 10.4415/ANN_22_04_02
Massimo D'Archivio, Claudia Cataldo, Martina Del Manso, Daniele Petrone, Chiara Sacco, Maria Fenicia Vescio, Matteo Spuri, Maria Cristina Rota, Marco Bressi, Massimo Fabiani, Stefano Boros, Alberto Mateo Urdiales, Flavia Riccardo, Antonino Bella, Roberta Masella, Patrizio Pezzotti, Luca Busani

Introduction: Coronavirus disease 19 (COVID-19) is an infectious disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). To date, few data on clinical features and risk factors for disease severity and death by gender are available.

Aim: The current study aims to describe from a sex/gender perspective the characteristics of the SARS-CoV-2 cases occurred in the Italian population from February 2020 until October 2021.

Method and results: We used routinely collected data retrieved from the Italian National Surveillance System. The highest number of cases occurred among women between 40 and 59 years, followed by men in the same age groups. The proportion of deaths due to COVID-19 was higher in men (56.46%) compared to women (43.54%). Most of the observed deaths occurred in the elderly. Considering the age groups, the clinical outcomes differed between women and men in particular in cases over 80 years of age; with serious or critical conditions more frequent in men than in women.

Conclusions: Our data clearly demonstrate a similar number of cases in women and men, but with more severe disease and outcome in men, thus confirming the importance to analyse the impact of sex and gender in new and emerging diseases.

简介:冠状病毒病19 (COVID-19)是一种由严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)引起的传染病。迄今为止,很少有按性别分列的关于疾病严重程度和死亡的临床特征和危险因素的数据。目的:本研究旨在从性别/性别角度描述2020年2月至2021年10月意大利人群中发生的SARS-CoV-2病例的特征。方法和结果:我们使用从意大利国家监测系统检索的常规收集数据。40至59岁的女性患此病人数最多,同一年龄段的男性次之。男性新冠肺炎死亡比例(56.46%)高于女性(43.54%)。大多数观察到的死亡发生在老年人中。考虑到年龄组,临床结果在女性和男性之间存在差异,特别是在80岁以上的病例中;有严重或危急情况的男性比女性更常见。结论:我们的数据清楚地表明,女性和男性的病例数量相似,但男性的疾病和结局更严重,从而证实了分析性别和性别对新发疾病的影响的重要性。
{"title":"Characteristics of COVID-19 cases in Italy from a sex/gender perspective.","authors":"Massimo D'Archivio,&nbsp;Claudia Cataldo,&nbsp;Martina Del Manso,&nbsp;Daniele Petrone,&nbsp;Chiara Sacco,&nbsp;Maria Fenicia Vescio,&nbsp;Matteo Spuri,&nbsp;Maria Cristina Rota,&nbsp;Marco Bressi,&nbsp;Massimo Fabiani,&nbsp;Stefano Boros,&nbsp;Alberto Mateo Urdiales,&nbsp;Flavia Riccardo,&nbsp;Antonino Bella,&nbsp;Roberta Masella,&nbsp;Patrizio Pezzotti,&nbsp;Luca Busani","doi":"10.4415/ANN_22_04_02","DOIUrl":"https://doi.org/10.4415/ANN_22_04_02","url":null,"abstract":"<p><strong>Introduction: </strong>Coronavirus disease 19 (COVID-19) is an infectious disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). To date, few data on clinical features and risk factors for disease severity and death by gender are available.</p><p><strong>Aim: </strong>The current study aims to describe from a sex/gender perspective the characteristics of the SARS-CoV-2 cases occurred in the Italian population from February 2020 until October 2021.</p><p><strong>Method and results: </strong>We used routinely collected data retrieved from the Italian National Surveillance System. The highest number of cases occurred among women between 40 and 59 years, followed by men in the same age groups. The proportion of deaths due to COVID-19 was higher in men (56.46%) compared to women (43.54%). Most of the observed deaths occurred in the elderly. Considering the age groups, the clinical outcomes differed between women and men in particular in cases over 80 years of age; with serious or critical conditions more frequent in men than in women.</p><p><strong>Conclusions: </strong>Our data clearly demonstrate a similar number of cases in women and men, but with more severe disease and outcome in men, thus confirming the importance to analyse the impact of sex and gender in new and emerging diseases.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10342988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
A case of medicine in disguise: motion sickness patches sold as medical devices containing active pharmaceutical substances. 一个变相药物的案例:晕动病贴片作为含有活性药物物质的医疗设备出售。
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2022-10-01 DOI: 10.4415/ANN_22_04_05
Maria Cristina Gaudiano, Paola Bertocchi, Daniela De Orsi, Livia Manna, Eleonora Antoniella, Andrea Rodomonte, Angela Sorbo, Federica Aureli, Monica Bartolomei

Introduction: A case study is reported on anti-motion sickness transdermal patches sold in the Internet, claiming to contain only natural ingredients but, actually, containing undeclared medicinal active substances. The visual inspection of the samples evidenced many inconsistencies in secondary and primary packaging, missing of various legal information and a non-compliant "CE" mark.

Methods: The qualitative analysis was performed by liquid chromatography - high resolution mass spectrometry and the quantitative by liquid chromatography with diode array detector.

Results: The analyses evidenced the presence of the antihistaminic drug Diphenhydramine and of other active substances (Capsaicin, a transdermal absorption enhancer, and Diclofenac in traces, probably a contaminant from other productions of the same plant). Moreover, the presence of several trace elements, including those potentially toxic to humans, was assessed by ICP-MS analysis.

Conclusions: The case discussed is a new case of "medicines in disguise" never reported in literature, and shows the presence of tangible risks for public health.

导言:一个案例研究报道了在互联网上出售的抗晕动病透皮贴片,声称只含有天然成分,但实际上含有未申报的药用活性物质。对样品的目视检查表明,二级包装和初级包装有许多不一致之处,缺少各种法律信息,并且不符合“CE”标志。方法:采用液相色谱-高分辨质谱法进行定性分析,液相色谱-二极管阵列检测器进行定量分析。结果:分析证明了抗组胺药苯海拉明和其他活性物质的存在(辣椒素,一种透皮吸收促进剂,微量双氯芬酸,可能是同一植物其他产品的污染物)。此外,通过ICP-MS分析评估了几种微量元素的存在,包括那些对人类有潜在毒性的元素。结论:所讨论的病例是文献中从未报道过的“变相药物”的新病例,表明存在切实的公共卫生风险。
{"title":"A case of medicine in disguise: motion sickness patches sold as medical devices containing active pharmaceutical substances.","authors":"Maria Cristina Gaudiano,&nbsp;Paola Bertocchi,&nbsp;Daniela De Orsi,&nbsp;Livia Manna,&nbsp;Eleonora Antoniella,&nbsp;Andrea Rodomonte,&nbsp;Angela Sorbo,&nbsp;Federica Aureli,&nbsp;Monica Bartolomei","doi":"10.4415/ANN_22_04_05","DOIUrl":"https://doi.org/10.4415/ANN_22_04_05","url":null,"abstract":"<p><strong>Introduction: </strong>A case study is reported on anti-motion sickness transdermal patches sold in the Internet, claiming to contain only natural ingredients but, actually, containing undeclared medicinal active substances. The visual inspection of the samples evidenced many inconsistencies in secondary and primary packaging, missing of various legal information and a non-compliant \"CE\" mark.</p><p><strong>Methods: </strong>The qualitative analysis was performed by liquid chromatography - high resolution mass spectrometry and the quantitative by liquid chromatography with diode array detector.</p><p><strong>Results: </strong>The analyses evidenced the presence of the antihistaminic drug Diphenhydramine and of other active substances (Capsaicin, a transdermal absorption enhancer, and Diclofenac in traces, probably a contaminant from other productions of the same plant). Moreover, the presence of several trace elements, including those potentially toxic to humans, was assessed by ICP-MS analysis.</p><p><strong>Conclusions: </strong>The case discussed is a new case of \"medicines in disguise\" never reported in literature, and shows the presence of tangible risks for public health.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10342989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Key performance indicators of breast cancer screening programmes in Italy, 2011-2019. 2011-2019年意大利乳腺癌筛查项目关键绩效指标
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2022-10-01 DOI: 10.4415/ANN_22_04_04
Francesca Battisti, Paola Mantellini, Patrizia Falini, Leonardo Ventura, Livia Giordano, Gianni Saguatti, Marco Zappa, Silvia Deandrea, Giuseppe Gorini

Introduction: Performance indicators for organised breast cancer screening programmes in Italy, 2011-2019, were evaluated.

Materials and methods: Aggregated data were gathered by the National Centre for Screening Monitoring from over 150 regional or sub-regional screening programmes in Italy. Invitation and examination coverage, participation rate (PR), recall rate (RR), detection rate, positive predictive value (PPV) for the target population as a whole (women aged 50-69), by 5-year age-class, geographical macro-area (North, Centre, South-Islands with the exception of three Regions for missing/uncomplete data) and Region were estimated.

Results: Coverage showed an increasing positive trend, especially in the South-Islands, and PR was stable all over Italy. On the other hand, an increasing RR and decreasing PPV were recorded, especially at the first screening test and in some regions.

Discussion and conclusions: The positive increase in coverage is accompanied by a worsening of some performance indicators for which a better resource allocation and staff training are required. For this reason, further and continuous monitoring is mandatory.

前言:对2011-2019年意大利有组织乳腺癌筛查项目的绩效指标进行了评估。材料和方法:意大利国家筛查监测中心从150多个区域或分区域筛查方案中收集了汇总数据。对目标人群(50-69岁女性)的邀请和检查覆盖率、参与率(PR)、召回率(RR)、检出率、阳性预测值(PPV)、按5岁年龄组、地理宏观区域(北部、中部、南部岛屿,数据缺失/不完整的三个地区除外)和地区进行估计。结果:覆盖率呈上升趋势,特别是在南岛,PR在意大利全境保持稳定。另一方面,在一些地区,特别是在第一次筛查时,记录到RR升高和PPV降低。讨论和结论:覆盖率的积极增加伴随着一些业绩指标的恶化,为此需要更好的资源分配和工作人员培训。出于这个原因,进一步和持续的监控是必须的。
{"title":"Key performance indicators of breast cancer screening programmes in Italy, 2011-2019.","authors":"Francesca Battisti,&nbsp;Paola Mantellini,&nbsp;Patrizia Falini,&nbsp;Leonardo Ventura,&nbsp;Livia Giordano,&nbsp;Gianni Saguatti,&nbsp;Marco Zappa,&nbsp;Silvia Deandrea,&nbsp;Giuseppe Gorini","doi":"10.4415/ANN_22_04_04","DOIUrl":"https://doi.org/10.4415/ANN_22_04_04","url":null,"abstract":"<p><strong>Introduction: </strong>Performance indicators for organised breast cancer screening programmes in Italy, 2011-2019, were evaluated.</p><p><strong>Materials and methods: </strong>Aggregated data were gathered by the National Centre for Screening Monitoring from over 150 regional or sub-regional screening programmes in Italy. Invitation and examination coverage, participation rate (PR), recall rate (RR), detection rate, positive predictive value (PPV) for the target population as a whole (women aged 50-69), by 5-year age-class, geographical macro-area (North, Centre, South-Islands with the exception of three Regions for missing/uncomplete data) and Region were estimated.</p><p><strong>Results: </strong>Coverage showed an increasing positive trend, especially in the South-Islands, and PR was stable all over Italy. On the other hand, an increasing RR and decreasing PPV were recorded, especially at the first screening test and in some regions.</p><p><strong>Discussion and conclusions: </strong>The positive increase in coverage is accompanied by a worsening of some performance indicators for which a better resource allocation and staff training are required. For this reason, further and continuous monitoring is mandatory.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10342991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Health Belief Model efficacy in explaining and predicting intention or uptake influenza vaccination during pregnancy. 健康信念模型在解释和预测妊娠期流感疫苗接种意向的有效性。
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2022-10-01 DOI: 10.4415/ANN_22_04_09
Francesca Zambri, Alessia Quattrini, Ilaria Perilli, Stefania Spila Alegiani, Francesca Marchetti, Sofia Colaceci, Angela Giusti

Introduction: The influenza vaccination is a priority during pregnancy due to infection-related-outcomes. The study aim is to assess the acceptance by women of influenza vaccination during pregnancy based on Health Belief Model (HBM).

Methods: A multicentre observational study was carried out with a convenience sample of 300 respondents.

Results: Most women (53.7%) declared that they worried to contract influenza during pregnancy and 80.7% of them agreed that there is a risk of contracting influenza during the first months of life. Vaccine benefits (adjOR 4.3 CI 95% 1.7-10.9 p <0.01), information on vaccination (adjOR 2.6 CI 95% 1.2-5.5 p <0.01) and trust in guidelines (adjOR 3.5 CI 95% 1.6-7.3 p <0.01) are some factors associated with intent/vaccination during pregnancy.

Conclusions: HBM confirms its effectiveness in explaining/predicting health behaviours. It is necessary to create trust in the vaccinations through an integrated work of health professionals to set up training programs and to provide effective health communication.

由于感染相关的后果,流感疫苗接种是妊娠期间的优先事项。本研究的目的是基于健康信念模型(Health Belief Model, HBM)评估孕妇对妊娠期流感疫苗接种的接受程度。方法:采用300名方便样本进行多中心观察性研究。结果:大多数妇女(53.7%)声称她们担心在怀孕期间感染流感,其中80.7%同意在出生后的头几个月有感染流感的风险。疫苗益处(adjOR 4.3 CI 95% 1.7-10.9 p)结论:HBM证实了其解释/预测健康行为的有效性。有必要通过卫生专业人员的综合工作,建立对疫苗接种的信任,建立培训计划,并提供有效的卫生沟通。
{"title":"Health Belief Model efficacy in explaining and predicting intention or uptake influenza vaccination during pregnancy.","authors":"Francesca Zambri,&nbsp;Alessia Quattrini,&nbsp;Ilaria Perilli,&nbsp;Stefania Spila Alegiani,&nbsp;Francesca Marchetti,&nbsp;Sofia Colaceci,&nbsp;Angela Giusti","doi":"10.4415/ANN_22_04_09","DOIUrl":"https://doi.org/10.4415/ANN_22_04_09","url":null,"abstract":"<p><strong>Introduction: </strong>The influenza vaccination is a priority during pregnancy due to infection-related-outcomes. The study aim is to assess the acceptance by women of influenza vaccination during pregnancy based on Health Belief Model (HBM).</p><p><strong>Methods: </strong>A multicentre observational study was carried out with a convenience sample of 300 respondents.</p><p><strong>Results: </strong>Most women (53.7%) declared that they worried to contract influenza during pregnancy and 80.7% of them agreed that there is a risk of contracting influenza during the first months of life. Vaccine benefits (adjOR 4.3 CI 95% 1.7-10.9 p <0.01), information on vaccination (adjOR 2.6 CI 95% 1.2-5.5 p <0.01) and trust in guidelines (adjOR 3.5 CI 95% 1.6-7.3 p <0.01) are some factors associated with intent/vaccination during pregnancy.</p><p><strong>Conclusions: </strong>HBM confirms its effectiveness in explaining/predicting health behaviours. It is necessary to create trust in the vaccinations through an integrated work of health professionals to set up training programs and to provide effective health communication.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10342992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Italians are still loyal to conventional cigarettes, despite novel tobacco products. 尽管有新型烟草产品,意大利人仍然忠于传统香烟。
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2022-10-01 DOI: 10.4415/ANN_22_04_06
Giulia Carreras, Valentina Minardi, Alessandra Lugo, Silvano Gallus, Maria Masocco, Lorenzo Spizzichino, Giuseppe Gorini

Introduction: Over the last few decades in Italy, we observed a substantial reduction in conventional tobacco cigarette consumption, the introduction of electronic cigarettes (e-cigarette) in 2010, and the launch of heated tobacco products (HTP) in 2015.

Methods: We investigated novel products, i.e. e-cigarettes and HTP, use in Italy in 2018-2021 using data from the cross-sectional annual PASSI (Progressi delle Aziende Sanitarie per la Salute in Italia) survey conducted in representative samples of adults aged 18-69 (overall n = 101,458). We compared characteristics of conventional cigarette smokers with those of novel product users.

Results: A stall in e-cigarette use at around 2.4% and a three-fold increase in HTP use from 0.5% in 2018 to 2.5% in 2021 were recorded, with around 60% of e-cigarette users and 70% of HTP users who kept on smoking conventional cigarettes. Around 86% of smokers did not use novel products at all. Novel products use among former smokers was more likely in younger e-cigarette with no nicotine users, whereas older users of both novel products were less able to completely shift to an exclusive use.

Conclusions: After 10 years from the introduction of e-cigarettes and 5 years from that of HTP, the majority of smokers in Italy were still loyal to conventional tobacco cigarettes, and more than half of novel product users kept on smoking conventional cigarettes.

导言:在过去几十年里,我们观察到意大利传统烟草卷烟的消费量大幅减少,2010 年引入了电子烟(e-cigarette),2015 年推出了加热烟草产品(HTP):我们调查了2018-2021年意大利新型产品(即电子烟和加热烟草制品)的使用情况,使用的数据来自PASSI(Progressi delle Aziende Sanitarie per la Salute in Italia)年度横断面调查,调查对象为18-69岁的代表性成年人样本(总体n = 101,458)。我们比较了传统卷烟吸食者和新型产品使用者的特征:根据记录,电子烟的使用率停滞在 2.4% 左右,HTP 的使用率增长了三倍,从 2018 年的 0.5% 增长到 2021 年的 2.5%,其中约 60% 的电子烟使用者和 70% 的 HTP 使用者仍在吸食传统香烟。约 86% 的吸烟者完全不使用新型产品。年轻的无尼古丁电子烟使用者更有可能在以前的吸烟者中使用新型产品,而两种新型产品的老年使用者则较难完全转为完全使用新型产品:结论:在电子烟推出 10 年和 HTP 推出 5 年后,意大利大多数吸烟者仍忠于传统香烟,超过一半的新型产品使用者仍在吸传统香烟。
{"title":"Italians are still loyal to conventional cigarettes, despite novel tobacco products.","authors":"Giulia Carreras, Valentina Minardi, Alessandra Lugo, Silvano Gallus, Maria Masocco, Lorenzo Spizzichino, Giuseppe Gorini","doi":"10.4415/ANN_22_04_06","DOIUrl":"10.4415/ANN_22_04_06","url":null,"abstract":"<p><strong>Introduction: </strong>Over the last few decades in Italy, we observed a substantial reduction in conventional tobacco cigarette consumption, the introduction of electronic cigarettes (e-cigarette) in 2010, and the launch of heated tobacco products (HTP) in 2015.</p><p><strong>Methods: </strong>We investigated novel products, i.e. e-cigarettes and HTP, use in Italy in 2018-2021 using data from the cross-sectional annual PASSI (Progressi delle Aziende Sanitarie per la Salute in Italia) survey conducted in representative samples of adults aged 18-69 (overall n = 101,458). We compared characteristics of conventional cigarette smokers with those of novel product users.</p><p><strong>Results: </strong>A stall in e-cigarette use at around 2.4% and a three-fold increase in HTP use from 0.5% in 2018 to 2.5% in 2021 were recorded, with around 60% of e-cigarette users and 70% of HTP users who kept on smoking conventional cigarettes. Around 86% of smokers did not use novel products at all. Novel products use among former smokers was more likely in younger e-cigarette with no nicotine users, whereas older users of both novel products were less able to completely shift to an exclusive use.</p><p><strong>Conclusions: </strong>After 10 years from the introduction of e-cigarettes and 5 years from that of HTP, the majority of smokers in Italy were still loyal to conventional tobacco cigarettes, and more than half of novel product users kept on smoking conventional cigarettes.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10342994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Knowledge, attitude and barriers of the Italian National Guidelines System for the development of clinical practice guidelines: a cross-sectional survey of registered scientific-technical societies. 知识,态度和障碍的意大利国家指导系统的发展临床实践指南:注册科学技术协会的横断面调查。
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2022-10-01 DOI: 10.4415/ANN_22_04_07
Greta Castellini, Silvia Bargeri, Daniela Coclite, Daniela D'Angelo, Alice Josephine Fauci, Ornella Punzo, Antonello Napoletano, Primiano Iannone, Silvia Gianola

Background: To explore knowledge, attitude, and barriers of the Italian National Guidelines System (SNLG) for the development of clinical practice guidelines (CPG) among scientific-technical societies (STS) of health care professional.

Methods: A cross-sectional survey was distributed to the STS registered in the Italian Ministry of Health (n = 336). The questionnaire consisted of three sections: Respondent characteristics; Perception, knowledge, attitude, and use of CPGs; Knowledge of the SNLG.

Results: The survey sample was 194 (57.7%) STS: 69% STS members stated they "often consulted CPGs". Two out of three STS perceived scientific activities as extremely important. Additionally, 20.6% STS had submitted at least one CPG to the SNLG platform after the Gelli-Bianco Law went into effect (median 1 CPG; interquartile range, IQR, 1-4). The most often cited barrier (62.7%) to CPG submission was limited economic resources.

Conclusions: STS members hold a positive attitude towards CPGs despite barriers to CPG development.

背景:探讨意大利国家指南系统(SNLG)在卫生保健专业科学技术学会(STS)中制定临床实践指南(CPG)的知识、态度和障碍。方法:对在意大利卫生部登记的STS进行横断面调查(n = 336)。问卷由三部分组成:被调查者特征;感知、知识、态度和使用CPGs;了解SNLG。结果:调查样本194名(57.7%)STS: 69%的STS成员表示他们“经常咨询cpg”。三分之二的STS认为科学活动极其重要。此外,在Gelli-Bianco法案生效后,20.6%的STS向SNLG平台提交了至少一个CPG(中位数为1 CPG;四分位间距(IQR, 1-4)。提交CPG最常见的障碍(62.7%)是有限的经济资源。结论:STS成员对CPG的态度是积极的,尽管CPG的发展存在障碍。
{"title":"Knowledge, attitude and barriers of the Italian National Guidelines System for the development of clinical practice guidelines: a cross-sectional survey of registered scientific-technical societies.","authors":"Greta Castellini,&nbsp;Silvia Bargeri,&nbsp;Daniela Coclite,&nbsp;Daniela D'Angelo,&nbsp;Alice Josephine Fauci,&nbsp;Ornella Punzo,&nbsp;Antonello Napoletano,&nbsp;Primiano Iannone,&nbsp;Silvia Gianola","doi":"10.4415/ANN_22_04_07","DOIUrl":"https://doi.org/10.4415/ANN_22_04_07","url":null,"abstract":"<p><strong>Background: </strong>To explore knowledge, attitude, and barriers of the Italian National Guidelines System (SNLG) for the development of clinical practice guidelines (CPG) among scientific-technical societies (STS) of health care professional.</p><p><strong>Methods: </strong>A cross-sectional survey was distributed to the STS registered in the Italian Ministry of Health (n = 336). The questionnaire consisted of three sections: Respondent characteristics; Perception, knowledge, attitude, and use of CPGs; Knowledge of the SNLG.</p><p><strong>Results: </strong>The survey sample was 194 (57.7%) STS: 69% STS members stated they \"often consulted CPGs\". Two out of three STS perceived scientific activities as extremely important. Additionally, 20.6% STS had submitted at least one CPG to the SNLG platform after the Gelli-Bianco Law went into effect (median 1 CPG; interquartile range, IQR, 1-4). The most often cited barrier (62.7%) to CPG submission was limited economic resources.</p><p><strong>Conclusions: </strong>STS members hold a positive attitude towards CPGs despite barriers to CPG development.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10342990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annali dell'Istituto superiore di sanita
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1